At present, mitral heart valve failure is treated through invasive surgery or via a transcatheter procedure called Transcatheter Edge-to-Edge Repair (TEER). However, this procedure is difficult to perform, potentially resulting in suboptimal outcomes in challenging cases and if done by inexperienced clinicians.
To address this, Moray Medical, a company based in Mountain View, California, has developed a robotic catheter and associated technology, including augmented reality and a 3D digital interface, designed to make the job easier. In fact, the company claims that using its technology to deliver cardiac therapies can be as simple as moving a cursor on a computer screen.
The company hopes that its offerings will enable effective mitral heart valve repair outside of specialized centers of excellence, thereby expanding the number of patients who can avail of the treatment. Moray Medical was recently shortlisted for the MedTech Innovator, 2020 Grand Prize for its device.